CA Stock MarketDetailed Quotes

MRVL Marvel Biosciences Corp

Watchlist
  • 0.115
  • 0.0000.00%
15min DelayMarket Closed Jul 18 16:00 ET
4.58MMarket Cap-1916P/E (TTM)

Marvel Biosciences Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-78.28%217.69K
93.64%577.67K
-40.85%316.98K
-6.17%556.62K
-6.17%556.62K
55.78%1M
-65.28%298.33K
-74.71%535.93K
-75.21%593.21K
-75.21%593.21K
-Cash and cash equivalents
-78.28%217.69K
93.64%577.67K
-40.85%316.98K
-6.17%556.62K
-6.17%556.62K
55.78%1M
-65.28%298.33K
-74.71%535.93K
-75.21%593.21K
-75.21%593.21K
-Other receivables
-85.35%87.88K
-79.24%85.38K
-79.60%82.88K
-67.18%149.63K
-67.18%149.63K
341.45%599.66K
193.01%411.3K
48.44%406.19K
311.05%455.91K
311.05%455.91K
Total current assets
-71.54%347.27K
11.26%711.16K
-48.19%434.75K
-26.40%672.39K
-26.40%672.39K
70.83%1.22M
-30.61%639.19K
-60.96%839.12K
-62.98%913.54K
-62.98%913.54K
Non current assets
-Long term equity investment
76.73%1.5M
--1.5M
--1M
--1M
--1M
--848.76K
----
----
----
----
-Other intangible assets
----
----
----
----
----
----
----
----
---30K
---30K
Regulatory assets
55.36%107.76K
67.44%100.97K
91.32%92.67K
45.14%81.91K
45.14%81.91K
44.55%69.36K
82.24%60.3K
227.53%48.44K
-4.51%56.44K
-4.51%56.44K
Total assets
55.36%107.76K
67.44%100.97K
91.32%92.67K
45.14%81.91K
45.14%81.91K
44.55%69.36K
82.24%60.3K
227.53%48.44K
-4.51%56.44K
-4.51%56.44K
Liabilities
Current liabilities
-accounts payable
391.04%1.41M
606.01%1.5M
644.06%1.53M
361.07%1.21M
361.07%1.21M
46.73%286.25K
4,133.41%212.98K
569.27%205.09K
16,668.71%262.1K
16,668.71%262.1K
-Total tax payable
76.73%1.5M
--1.5M
--1M
--1M
--1M
--848.76K
--0
--0
--0
--0
Current accrued expenses
679.59%111.07K
--76.55K
--54.58K
--34.41K
--34.41K
--14.25K
----
----
--0
--0
Current liabilities
78.25%1.6M
166.81%1.67M
172.12%1.66M
93.94%1.39M
93.94%1.39M
172.01%900.15K
329.36%624.28K
100.89%611.28K
538.36%718.01K
538.36%718.01K
Non current liabilities
Long term provisions
76.73%1.5M
--1.5M
--1M
--1M
--1M
--848.76K
----
----
----
----
Total non current liabilities
77.51%3.1M
407.08%3.17M
335.72%2.66M
233.21%2.39M
233.21%2.39M
428.50%1.75M
329.36%624.28K
100.89%611.28K
538.36%718.01K
538.36%718.01K
Shareholders'equity
Share capital
0.00%7.13M
0.00%7.13M
0.00%7.13M
3.87%7.13M
3.87%7.13M
10.33%7.13M
10.33%7.13M
10.33%7.13M
6.22%6.86M
6.22%6.86M
-common stock
0.00%7.13M
0.00%7.13M
0.00%7.13M
3.87%7.13M
3.87%7.13M
10.33%7.13M
10.33%7.13M
10.33%7.13M
6.22%6.86M
6.22%6.86M
Additional paid-in capital
-35.76%223.39K
25.12%218.88K
36.77%211.83K
65.66%202.14K
65.66%202.14K
249.41%347.74K
75.78%174.94K
55.62%154.88K
22.61%122.02K
22.61%122.02K
Total equity
-71.54%347.27K
11.26%711.16K
-48.19%434.75K
-26.40%672.39K
-26.40%672.39K
70.83%1.22M
-30.61%639.19K
-60.97%839.12K
-62.99%913.54K
-62.99%913.54K
(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022(FY)Jul 31, 2022(Q4)Jul 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -78.28%217.69K93.64%577.67K-40.85%316.98K-6.17%556.62K-6.17%556.62K55.78%1M-65.28%298.33K-74.71%535.93K-75.21%593.21K-75.21%593.21K
-Cash and cash equivalents -78.28%217.69K93.64%577.67K-40.85%316.98K-6.17%556.62K-6.17%556.62K55.78%1M-65.28%298.33K-74.71%535.93K-75.21%593.21K-75.21%593.21K
-Other receivables -85.35%87.88K-79.24%85.38K-79.60%82.88K-67.18%149.63K-67.18%149.63K341.45%599.66K193.01%411.3K48.44%406.19K311.05%455.91K311.05%455.91K
Total current assets -71.54%347.27K11.26%711.16K-48.19%434.75K-26.40%672.39K-26.40%672.39K70.83%1.22M-30.61%639.19K-60.96%839.12K-62.98%913.54K-62.98%913.54K
Non current assets
-Long term equity investment 76.73%1.5M--1.5M--1M--1M--1M--848.76K----------------
-Other intangible assets -----------------------------------30K---30K
Regulatory assets 55.36%107.76K67.44%100.97K91.32%92.67K45.14%81.91K45.14%81.91K44.55%69.36K82.24%60.3K227.53%48.44K-4.51%56.44K-4.51%56.44K
Total assets 55.36%107.76K67.44%100.97K91.32%92.67K45.14%81.91K45.14%81.91K44.55%69.36K82.24%60.3K227.53%48.44K-4.51%56.44K-4.51%56.44K
Liabilities
Current liabilities
-accounts payable 391.04%1.41M606.01%1.5M644.06%1.53M361.07%1.21M361.07%1.21M46.73%286.25K4,133.41%212.98K569.27%205.09K16,668.71%262.1K16,668.71%262.1K
-Total tax payable 76.73%1.5M--1.5M--1M--1M--1M--848.76K--0--0--0--0
Current accrued expenses 679.59%111.07K--76.55K--54.58K--34.41K--34.41K--14.25K----------0--0
Current liabilities 78.25%1.6M166.81%1.67M172.12%1.66M93.94%1.39M93.94%1.39M172.01%900.15K329.36%624.28K100.89%611.28K538.36%718.01K538.36%718.01K
Non current liabilities
Long term provisions 76.73%1.5M--1.5M--1M--1M--1M--848.76K----------------
Total non current liabilities 77.51%3.1M407.08%3.17M335.72%2.66M233.21%2.39M233.21%2.39M428.50%1.75M329.36%624.28K100.89%611.28K538.36%718.01K538.36%718.01K
Shareholders'equity
Share capital 0.00%7.13M0.00%7.13M0.00%7.13M3.87%7.13M3.87%7.13M10.33%7.13M10.33%7.13M10.33%7.13M6.22%6.86M6.22%6.86M
-common stock 0.00%7.13M0.00%7.13M0.00%7.13M3.87%7.13M3.87%7.13M10.33%7.13M10.33%7.13M10.33%7.13M6.22%6.86M6.22%6.86M
Additional paid-in capital -35.76%223.39K25.12%218.88K36.77%211.83K65.66%202.14K65.66%202.14K249.41%347.74K75.78%174.94K55.62%154.88K22.61%122.02K22.61%122.02K
Total equity -71.54%347.27K11.26%711.16K-48.19%434.75K-26.40%672.39K-26.40%672.39K70.83%1.22M-30.61%639.19K-60.97%839.12K-62.99%913.54K-62.99%913.54K

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg